Direct healthcare professional communication on updates to PML risk minimisation measures for Tysabri (natalizumab)
16.03.2016
more
Pharmacovigilance
EMA reviews cancer medicine Zydelig
15.03.2016
more
Direct healthcare professional communication with updated information on the risk of diabetic ketoacidosis during treatment with SGLT2 inhibitors (Invokana*, Vokanamet*, Forxiga, Xigduo, Jardiance, Synjardy*)
14.03.2016
more
CMDh News – February 2016
07.03.2016
more
CHMP News – February 2016
29.02.2016
more
Beginning of a review of medicines containing dienogest 2 mg and ethinylestradiol 0.03 mg when used for acne
29.02.2016
more
EMA confirms recommendations to minimise risk of brain infection PML with Tysabri
29.02.2016
more
EMA confirms recommendations to minimise ketoacidosis risk with SGLT2 inhibitors for diabetes
29.02.2016
more
PRAC News – February 2016
15.02.2016
more
Updated recommendations to minimise the risk of the rare brain infection PML with Tysabri
15.02.2016
more
